Strainprint™ Closes USD $3 Million (Cdn.$3.8M) Series A Funding

TORONTO, May 8, 2018 /PRNewswire/ – StrainprintTM Technologies — the leader in cannabis data and analytics is pleased to announce the closing of a USD $3 Million (Cdn.$3.8 Million) non-brokered, Series A private placement. The round was led by strategic industry investor, Cesare Fazari, Chairman of Molecular Science Corp and seed investor of leading cannabis companies, Ample Organics and Hydropothecary. Mr. Fazari …

WSU researchers assess use of cannabis in treating stress, anxiety and depression Using Strainprint Technologies Ltd. Data

PULLMAN, WA – In a first-of-a-kind study, Washington State University scientists examined how peoples’ self-reported levels of stress, anxiety and depression were affected by smoking different strains and quantities of cannabis at home. Their work, published this month in the Journal of Affective Disorders, suggests smoking cannabis can significantly reduce short-term levels of depression, anxiety, …

Strainprint™ Technologies Ltd. (“Strainprint”) Welcomes Three Leading Cannabinoid Physicians to its Board

Dr. Caroline MacCallum, Dr. Danial Schecter & Dr. Dean Elterman Join Strainprint’s World-Class Medical Advisory Board TORONTO, April 17, 2018 /CNW/ – Strainprint, the leader in cannabis data & analytics, is pleased to announce that Dr. Caroline MacCallum, Dr. Danial Schecter and Dr. Dean Elterman have joined its Board of Medical Advisors. Strainprint works closely …

Strainprint President & CTO, David Berg Featured in Cannabis Investing News

The legalization of cannabis has allowed researchers to begin investigating the drug at more in-depth levels than before. With the current state of cannabis working towards legalization across the globe, new channels of research are opening up across the board as an effort to rapidly catch up with a market ready to consume a product …

download the app